搜索临床试验以:BCR-ABL TKI
总计546个结果
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte Corporation; H. Jean Khoury Cure CML Consortium招聘中
-
Shenzhen Second People's Hospital招聘中白血病 | 骨髓的 | 慢性的 | BCR-ABL (Breakpoint Cluster Region-abelson Murine Leukemia) | 积极的中国
-
Novartis Pharmaceuticals主动,不招人
-
University of Milano BicoccaIRCCS San Raffaele完全的白血病 | BCR-ABL阳性 | 骨髓的 | 慢性的意大利
-
National Research Center for Hematology, Russia主动,不招人
-
Novartis Pharmaceuticals尚未招聘白血病,骨髓性,慢性,BCR-ABL 阳性
-
Peking University People's HospitalHenan Cancer Hospital; Wuhan Union Hospital, China; Zhejiang University; Peking Union Medical College 和其他合作者尚未招聘
-
Tianjin Medical University Cancer Institute and...招聘中非小细胞肺癌 | EGFR激活突变 | EGFR-TKI 耐药突变 | 细胞周期失调中国
-
Avistone Biotechnology Co., Ltd.招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Guangzhou Medical University招聘中
-
Guangzhou University of Traditional Chinese MedicineAkeso Pharmaceuticals, Inc.招聘中
-
Ocular Therapeutix, Inc.Duke University; Fortrea招聘中
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘非小细胞肺癌 | ERBB2突变相关肿瘤 | Disitamab Vedotin | ERBB2基因重复
-
Gene Solutions招聘中非小细胞肺癌 | IIIB 期非小细胞肺癌 | IV 期非小细胞肺癌 | IIIC 期非小细胞肺癌 | 酪氨酸激酶抑制剂越南
-
Terns, Inc.尚未招聘
-
Bristol-Myers SquibbZai Lab (Shanghai) Co., Ltd.招聘中癌,非小细胞肺癌日本, 中国, 加拿大, 西班牙, 德国, 大韩民国, 奥地利, 巴西, 希腊, 法国, 美国, 意大利, 阿根廷, 智利, 匈牙利, 印度, 火鸡, 罗马尼亚, 瑞士, 荷兰, 波兰
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Wageningen UniversityNext Food Collective (previously TKI agri-food program and TiFN, Top Institute Food and Nutrition)招聘中
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.尚未招聘
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...招聘中
-
China Medical University Hospital尚未招聘非小细胞肺癌 | 表皮生长因子受体基因突变 | EGFR-TKI 耐药突变
-
Degan LuWu Jieping Medical Foundation尚未招聘肺癌 | 安罗替尼 | TKI耐药 | EGFR敏感突变 | 平珠单抗
-
RenJi HospitalShanghai Zhongshan Hospital; Ruijin Hospital招聘中